http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
신이식 환자의 항체매개성 거부반응에서 Bortezomib으로 치료한
박세정 ( Se Jeong Park ),유훈 ( Hoon Yu ),강성희 ( Sung Hee Kang ),백승돈 ( Seung Don Baek ),백충희 ( Chung Hee Baek ),정재호 ( Jae Ho Jeong ),박수길 ( Su Kil Park ) 대한내과학회 2011 대한내과학회지 Vol.81 No.6
Donor-specific anti-human leukocyte antigen antibodies (DSA) following kidney transplantation predict the evolution of humoral rejection and reduced graft survival. Rapid, complete elimination of DSA during antibody-mediated rejection (AMR) is rarely achieved with traditional antihumoral therapies. We report the case of a 39-year-old female who was admitted for increasing azotemia and diagnosed with AMR based on diffusely positive histological changes on C4d immunostaining. In this case, bortezomib reversed the histological changes and induced a reduction in DSA. Proteasome-inhibitor-based combination therapy is a potential means for rapid DSA elimination in antibody-mediated rejection in renal transplant recipients. (Korean J Med 2011;81:780-785)
실험적 신질환 : 실험적 당뇨 백서에서 proteasome inhibitor인 Bortezomib의 세포외 기질 축적에 대한 효과
강이화 ( Ea Wha Kang ),한승혁 ( Seung Hyeok Han ),최영춘 ( Ying Chun Cui ),정동섭 ( Dong Sub Jung ),이금희 ( Jin Ji Li ),이순하 ( Sun Ha Lee ),김승혜 ( Seung Hye Kim ),곽승재 ( Seung Jae Kwak ),박제현 ( Je Hyun Park ),유태현 ( Tae 대한신장학회 2008 춘계학술대회 초록집 Vol.28 No.1